Ā鶹ֱ²„

Ā鶹ֱ²„reiterates advice on COVID-19 vaccination

This statement covers COVID-19 vaccination and COVID-19 booster vaccination

RANZCOG

The Royal Australian and New Zealand College of Obstetricians and Gynaecologists

Updated
12 July 2024
SHARE

The peak body for obstetrics and gynaecology and womenā€™s health in Australia and Aotearoa New Zealand has reiterated the importance of COVID-19 vaccines.

mRNA vaccines for COVID-19 are recommended for all people trying to conceive (either spontaneously, or through IVF), pregnant, or breastfeeding. This advice is based on robust data supporting safety in these circumstances.

Specifically:

There is no evidence of negative impact on fertility

There is no evidence of an increased risk of miscarriage, stillbirth, preterm birth or other adverse pregnancy outcomes

There is no evidence of negative impacts on the health of the breastfed infant

Conversely, infection with COVID-19 is associated with an increased risk of severe disease, hospitalisation, admission to intensive care, mechanical ventilation, and death, in pregnant women, and an increased risk of prematurity and stillbirth.

ā€œProtect you and your baby ā€“ get the COVID-19 vaccine.ā€

Ā鶹ֱ²„President Dr Benjamin Bopp said: ā€œWhat poses the greatest risk to women and their babies is not the vaccine ā€” it is the COVID-19 infection itself.ā€

Booster vaccinations
 
A booster dose can be considered if you are 18 years, or older, and had your initial COVID-19 vaccine course (called the primary course) ā‰„ 6 months ago. Pfizer is the preferred brand for booster doses for all people, including in pregnancy, regardless of the brand used initially.
 
mRNA vaccines are safe and effective for those trying to conceive, pregnant and breastfeeding women. Booster doses have not yet been studied in those who are pregnant, but have been shown to be safe and effective in non-pregnant adults. Routine booster vaccinations in pregnancy are already recommended for whooping cough and influenza.
 
We do know that COVID-19 infection in pregnancy poses a significant risk for mothers and their babies. Ā鶹ֱ²„recommends that pregnant women receive booster vaccinations in line with the recommendations for the non-pregnant adult population

COVID-19 5 November 2021
Statement on booster vaccinations
A booster dose can be considered if you are 18 years, or older, and had your initial COVID-19 vaccine course (called the primary course) ā‰„ 6 months ago. Pfizer is the preferred brand for booster doses for all people, including in pregnancy, regardless of the brand used initially.
CATEGORIES
COVID-19 Women’s health

LATEST NEWS

Advocacy 15 January 2025
Principles of the Treaty of Waitangi Bill
Submission to the NZ Justice Committee called on the Government…
Advocacy 19 December 2024
Roundtable Report: Driving Collective Reform in Private O&G
Urgent collective reform is needed to protect private O&G services.
Aotearoa New Zealand 16 December 2024
Kua hinga te tōtara o te wao nui a Tāne – A mighty tōtara tree has fallen in Tāne’s great forest
Ā鶹ֱ²„mourns the passing of kaumatua Luke Crawford.
Our Members 22 November 2024
Ā鶹ֱ²„Extraordinary General Meeting
Extraordinary General Meeting (EGM) of Fellows of the Ā鶹ֱ²„will…
Advocacy 18 November 2024
Ā鶹ֱ²„reaffirms commitment to Te Tiriti o Waitangi and health equity
Ā鶹ֱ²„is committed to continuing the journey towards equity and…
Advocacy 14 November 2024
Private O&G Services Under Threat in Australia Due to Systemic Gender Bias
Ā鶹ֱ²„leads call for urgent reform in private obstetrics and…
Training 1 November 2024
RANZCOGā€™s Fetal Surveillance Education Program Achieves Record Numbers
The Ā鶹ֱ²„Fetal Surveillance Education Program has achieved over 36,000…